Erythropoietin protects against rhabdomyolysis-induced acute kidney injury by modulating macrophage polarization

Erythropoietin (EPO) is a well-known hormone that is clinically used for the treatment of anemia. Very recently, an increasing body of evidence showed that EPO could still regulate bioactivities of macrophages. However, the details about the immunomodulatory effect of EPO on macrophages are not full...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cell Death Dis
Hlavní autoři: Wang, Shuo, Zhang, Chao, Li, Jiawei, Niyazi, Sidikejiang, Zheng, Long, Xu, Ming, Rong, Ruiming, Yang, Cheng, Zhu, Tongyu
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5477572/
https://ncbi.nlm.nih.gov/pubmed/28383559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.104
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky